General Motors (GM) has filed a new patent application designed to significantly improve the torque response of turbocharged engines, a crucial enhancement for modern automotive performance and fuel efficiency. The patent, assigned the number US 2025/0052207 A1 by the United States Patent and Trademark Office (USPTO), was published today, offering insight into GM’s latest technological […]
The Association of American Publishers (AAP) recently submitted a response to the White House Office of Science and Technology Policy’s call for public comment on the Artificial Intelligence Action Plan. The AAP’s submission underscores the importance of robust copyright protections for ensuring the United States remains a global leader in both technology and intellectual property
In a significant ruling, the U.S. Court of Appeals for the Federal Circuit has rejected an argument that the Patent Trial and Appeal Board (PTAB) lacks jurisdiction to conduct an inter partes review (IPR) on expired patents. This decision clarifies that the PTAB’s authority is not tied to whether a patent is active or expired,
Three years after the University of Pennsylvania accused Roche of infringing its intellectual property related to breast cancer medications, the dispute has been resolved just weeks before a scheduled jury trial. The lawsuit, filed by Penn in 2022 in the U.S. District Court for Delaware, claimed that Roche and its Genentech unit had infringed on
The rise of generative artificial intelligence (AI) has had a profound impact across industries, from technology to creative fields. AI systems capable of generating computer code, writing news articles, and producing professional-grade graphics have spurred widespread debates about whether they will replace jobs in sectors like technology, journalism, and design, among others. Alongside these discussions
In a landmark decision, the Court of Justice of the European Union (CJEU) has clarified jurisdictional issues surrounding cross-border patent infringement disputes, opening the door for broader European legal recourse in national courts. The case, BSH Hausgeräte vs Electrolux (C-339/22), addresses critical questions related to the Brussels I bis Regulation, which governs jurisdiction in civil
At the end of 2023 and the beginning of 2024, Apple faced a significant setback as a patent dispute with Masimo temporarily blocked the sale of its Apple Watch Series 9 and flagship Apple Watch Ultra 2 in U.S. stores. The dispute centered around the use of Masimo’s blood oxygen sensor technology in the wearables,
Merck’s plans to expand the reach of its blockbuster cancer drug Keytruda with a new subcutaneous (injectable) formulation are encountering a significant obstacle. Halozyme Therapeutics has accused Merck of infringing on its patents related to the hyaluronidase enzyme, which is critical for drug delivery. This dispute could jeopardize Merck’s strategy to maintain Keytruda’s market dominance
Teva Pharmaceutical Industries Ltd. is pushing for the U.S. Supreme Court to review its ongoing patent dispute over asthma inhaler patents, after the U.S. Court of Appeals for the Federal Circuit denied the company’s request to reconsider a decision ordering Teva to delist five patents related to its ProAir HFA asthma inhaler from the FDA’s
Dr. A Ramarao, the Additional Project Coordinator for Samagra Shiksha, has been granted a Patent for 20-years by the Government of India for his groundbreaking innovation of the ‘Polymer Pulley-Driven Centrifugal Pump’. This patent was granted on March 4, 2025, and represents a major technological advancement in the field of mechanical engineering and in field
